129 related articles for article (PubMed ID: 22912433)
1. UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albumin.
Manevski N; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2012 Nov; 40(11):2192-203. PubMed ID: 22912433
[TBL] [Abstract][Full Text] [Related]
2. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
[TBL] [Abstract][Full Text] [Related]
3. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
Rowland A; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
[TBL] [Abstract][Full Text] [Related]
4. Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases.
Luukkanen L; Taskinen J; Kurkela M; Kostiainen R; Hirvonen J; Finel M
Drug Metab Dispos; 2005 Jul; 33(7):1017-26. PubMed ID: 15802387
[TBL] [Abstract][Full Text] [Related]
5. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
[TBL] [Abstract][Full Text] [Related]
6. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
[TBL] [Abstract][Full Text] [Related]
7. Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).
Zhou J; Argikar UA; Miners JO
Methods Mol Biol; 2021; 2342():301-338. PubMed ID: 34272700
[TBL] [Abstract][Full Text] [Related]
8. Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).
Zhou J; Miners JO
Methods Mol Biol; 2014; 1113():203-28. PubMed ID: 24523115
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
[TBL] [Abstract][Full Text] [Related]
10. The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.
Patana AS; Kurkela M; Goldman A; Finel M
Mol Pharmacol; 2007 Sep; 72(3):604-11. PubMed ID: 17578897
[TBL] [Abstract][Full Text] [Related]
11. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
Chrungoo VJ; Reen RK; Singh K; Singh J
Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
[TBL] [Abstract][Full Text] [Related]
12. Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic process.
Battaglia E; Pritchard M; Ouzzine M; Fournel-Gigleux S; Radominska A; Siest G; Magdalou J
Arch Biochem Biophys; 1994 Mar; 309(2):266-72. PubMed ID: 8135537
[TBL] [Abstract][Full Text] [Related]
13. Kinetic properties of UDP-glucuronosyltransferase(S) in different membranes of rat liver cells.
Antoine B; Magdalou J; Siest G
Xenobiotica; 1984 Jul; 14(7):575-9. PubMed ID: 6438924
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family.
Kobayashi T; Sleeman JE; Coughtrie MW; Burchell B
Biochem J; 2006 Dec; 400(2):281-9. PubMed ID: 16965264
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases.
Patana AS; Kurkela M; Finel M; Goldman A
Protein Eng Des Sel; 2008 Sep; 21(9):537-43. PubMed ID: 18502788
[TBL] [Abstract][Full Text] [Related]
16. SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases.
Ondo K; Arakawa H; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2020 May; 175():113916. PubMed ID: 32179043
[TBL] [Abstract][Full Text] [Related]
17. Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: implications for in vitro-in vivo extrapolation.
Rowland A; Gaganis P; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
J Pharmacol Exp Ther; 2007 Apr; 321(1):137-47. PubMed ID: 17237258
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the zebrafish Ugt repertoire reveals a new class of drug-metabolizing UDP glucuronosyltransferases.
Wang Y; Huang H; Wu Q
Mol Pharmacol; 2014 Jul; 86(1):62-75. PubMed ID: 24728488
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of UDP-glucuronosyltransferase activity in sea turtle
Dias VHV; Mattos JJ; Bastolla CLV; Lüchmann KH; Bainy ACD
Xenobiotica; 2022 Dec; 52(12):1011-1019. PubMed ID: 36594659
[TBL] [Abstract][Full Text] [Related]
20. The enzymatic mechanism of glucuronidation catalyzed by two purified rat liver steroid UDP-glucuronosyltransferases.
Falany CN; Green MD; Tephly TR
J Biol Chem; 1987 Jan; 262(3):1218-22. PubMed ID: 3100528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
